Navigation Links
Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits
Date:4/4/2011

ne BMI of 36.1. Throughout the 108-week treatment period, all patients were advised to follow a modest lifestyle modification program including reduction of food intake by 500 calories per day.  

About QNEXA Controlled Release Capsules

QNEXA [kyoo-nek-suh] is an investigational drug candidate being developed to address weight loss, type 2 diabetes and obstructive sleep apnea. QNEXA is a once-a-day, proprietary, oral, controlled-release formulation of low-dose phentermine and topiramate, which is designed to decrease appetite and increase satiety (the sense of feeling full), the two main mechanisms that impact eating behavior. In phase 2 and 3 clinical data to date, patients taking QNEXA have demonstrated statistically significant weight loss, glycemic control, and improvement in cardiovascular risk factors, when used in combination with a diet and lifestyle modification program.

About VIVUS

VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health. The company's lead product in clinical development, QNEXA®, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators. QNEXA® is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction. For more information about the company, please visit www.vivus.com


'/>"/>
SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. The Balance-Based Torso-Weighting® Treatment for Multiple Sclerosis Receives a NIH Recovery Act Grant
2. Medizone Internationals Mass-Market Sterilization Technology to be Produced by Canadian Medical Device Heavyweights
3. The Spatz Adjustable Balloon System® for Weight Loss Becomes the First Intragastric Balloon to Receive Regulatory Approval for 1 Year Implantation Time
4. Results of Innovative Clinical Study Show New Combination for Weight Loss Success
5. New Long-Term Data on QNEXA® Show Significant and Sustained Weight Loss of Greater Than 10% Over Two Years
6. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at One Year
7. New Data Demonstrates Victoza® (liraglutide [rDNA] injection) Provided Superior and Sustained Blood Sugar Control and Weight Reduction Compared to Januvia® (sitagliptin) at 52 Weeks
8. The Results are in: Users of BodyMedias Wearable Body-Monitoring Technology Lose 3 Times More Weight
9. ReShape Medical Announces Initiation of U.S. Clinical Study for Weight Loss
10. Womens Digital Imaging Using DXA Total Body Fat Analysis to Help Patients in Weight Management and Fitness Programs
11. New Survey Shows Seniors Struggle Under the Weight of Multiple Medication Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 Research and Markets ... the "North American Active Wound Care Market ... Wound, & Ulcer), by End-User (In-Patient, & Out-Paient) ... to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... to grow at a CAGR of 3.1% from ...
(Date:5/21/2015)... , May 21, 2015  CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today ... cash dividend for the second quarter 2015 of $0.03 ... dividend of $0.03 per share will be paid on ... as of June 12, 2015.  The ex-dividend date for ...
(Date:5/21/2015)... 2015 The Pharmaceutical Care Management Association ... Part D offsets included in the Energy & ... "If the 21st Century Cures initiative can only be ... program – Medicare – then its costs outweigh ... road. "Leveraging payments to Part D ...
Breaking Medicine Technology:North American Active Wound Care Market 2015-2019 with Smith and Nephew, Molyncke HealthCare & ConvaTec Dominating 2CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2
... Therapeutics (NYSE Amex: CXM ) is currently ... wound care product for the management of diabetic foot ... 2012 Spring Symposium on Advanced Wound Care (SAWC) being ... (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO ) The ...
... April 19, 2012 Masimo (NASDAQ: ... in the current issue of peer-reviewed journal BioScience ... Masimo Pleth Variability Index (PVI®) helps clinicians assess fluid ... results were similar to invasive, more expensive stroke volume ...
Cached Medicine Technology:Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care 2Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care 3Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care 4Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care 5New Study Shows Masimo's Noninvasive Pleth Variability Index Provides Similar Ability to Assess Fluid Responsiveness During Surgery as More Costly and Invasive Method 2New Study Shows Masimo's Noninvasive Pleth Variability Index Provides Similar Ability to Assess Fluid Responsiveness During Surgery as More Costly and Invasive Method 3New Study Shows Masimo's Noninvasive Pleth Variability Index Provides Similar Ability to Assess Fluid Responsiveness During Surgery as More Costly and Invasive Method 4New Study Shows Masimo's Noninvasive Pleth Variability Index Provides Similar Ability to Assess Fluid Responsiveness During Surgery as More Costly and Invasive Method 5
(Date:5/22/2015)... DMG Productions announces the upcoming airing ... on Friday, May 29, 2015 at 7:30 a.m. ET ... this episode Innovations will explore Interstate Restoration, a company ... through disaster recovery and restoration. , Additionally, the series ... to develop and deliver training and education in the ...
(Date:5/22/2015)... New York, NY (PRWEB) May 22, 2015 ... of Multifamily Housing, Marc Zuluaga, has been selected by ... innovative engineering. The award winners are featured in the ... given to 40 building industry professionals age 40 and ... to the building community, as well as in other ...
(Date:5/22/2015)... A new program for the "In America" television ... Physical Therapy. , James Earl Jones will host ... physical therapy and discusses how the exercises can decrease ... of ailments and injuries. Physical therapists work with ... enhances daily activities such as house cleaning and shopping, ...
(Date:5/22/2015)... In efforts to offer full and robust resources ... stretches has been a large focus over the last ... Chunk Fitness envisions a mid-June launch of these resources. ... at a later point in time. The current resources ... , About the Company: Chunk Fitness was founded in ...
(Date:5/22/2015)... Aliso Viejo, CA (PRWEB) May 22, 2015 ... 30 editable lower thirds designed exclusively for Final Cut ... creatively compatible with any design. , Intuitive on-screen-controls ... each unique lower third. Reflections, colors, layouts, and much ... the Inspector window. , Pro3rd Impression ...
Breaking Medicine News(10 mins):Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Developers at Pixel Film Studios Release Pro3rd Impression for Final Cut Pro X. 2
... it,s an accepted treatment in adults as well as ... 1990 and 2002, off-label use of anticancer drugs in ... percent, and most of that off-label use was for ... a number of countries. , In off-label use, a ...
... Nutter to Continue in Role of Chairman of the ... today that Brian Concannon will be promoted to the,position ... Brad,Nutter in this role. Brian will also join the ... continue as Chairman and CEO until,April 2009 and thereafter ...
... 27 HLTH Corporation,(Nasdaq: HLTH ) announced today that ... shares of its common stock at a price per share,of ... the tender offer,represents approximately 43% of HLTH,s currently outstanding shares. ... on the NASDAQ,Global Select Market on October 24, 2008 was ...
... row, HireRight, a leader in on-demand employment background ... Deloitte’s prestigious Technology Fast 50 Program for Orange ... technology, media, telecommunications and life sciences companies in ... nation’s leading professional services organizations. Rankings are based ...
... no gastrointestinal, side effects for people who need the ... ... Oct. 27 Announced today at the American,Dietetic Association, ... both heme (protein-based iron) and non-heme,iron (plant-based iron) will ...
... Medicine and Relationships With Healthcare,Facilities Are Among the ... Oct. 27 Decision Resources, one of the,world,s ... and,healthcare issues, has made available for free on ... 10 highlights of the Indian pharmaceutical market,that are ...
Cached Medicine News:Health News:Most Off-Label Cancer Drug Use for Palliative Care 2Health News:Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009 2Health News:Haemonetics Announces Promotion of Brian Concannon to CEO Effective April 2009 3Health News:HLTH Corporation Announces Commencement of Its Tender Offer 2Health News:HLTH Corporation Announces Commencement of Its Tender Offer 3Health News:HLTH Corporation Announces Commencement of Its Tender Offer 4Health News: HireRight Named to Deloitte Technology Fast 50 for the Sixth Year in a Row : Attributes Customer Focus and Innovative Screening Solutions to its 230 Percent Revenue Growth 2Health News: HireRight Named to Deloitte Technology Fast 50 for the Sixth Year in a Row : Attributes Customer Focus and Innovative Screening Solutions to its 230 Percent Revenue Growth 3Health News:First-Ever Over-the-Counter Dual Action Iron Supplement Launched at the American Dietetic Association Conference in Chicago; Bifera to be Available in Select Stores in Early 2009 2Health News:Top 10 Things Pharma Should Know About India - Free Paper From Decision Resources 2
Lambotte periosteal elevators....
Modified Freer periosteal elevator, #163, slight curve, 21 cm....
Williger periosteal elevator, 6 1/4", sharp, 5 mm wide....
Alley periosteal elevator, extra long, 21 cm, 8-1/4"....
Medicine Products: